CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos
In 2016, the EGF-Predictor Phase IV Clinical Trial Opening Workshop was held in Cienfuegos, sponsored by the Center for Molecular Immunology of Havana which coexist with other clinical trials. The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic va...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Universidad de las Ciencias Médicas de Cienfuegos
2017-04-01
|
| Series: | Revista Finlay |
| Subjects: | |
| Online Access: | https://revfinlay.sld.cu/index.php/finlay/article/view/531 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832577460859830272 |
|---|---|
| author | Yoana Herrera Leiva Teresita Sabatés Llerandi |
| author_facet | Yoana Herrera Leiva Teresita Sabatés Llerandi |
| author_sort | Yoana Herrera Leiva |
| collection | DOAJ |
| description | In 2016, the EGF-Predictor Phase IV Clinical Trial Opening Workshop was held in Cienfuegos, sponsored by the Center for Molecular Immunology of Havana which coexist with other clinical trials. The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic vaccine for the treatment of patients diagnosed with lung cancer in advanced stages of the disease and, within its specific objectives, to assess overall survival and the treated patients’ life quality. |
| format | Article |
| id | doaj-art-59dba8141ea741e9b28a74bd27af4f35 |
| institution | Kabale University |
| issn | 2221-2434 |
| language | Spanish |
| publishDate | 2017-04-01 |
| publisher | Universidad de las Ciencias Médicas de Cienfuegos |
| record_format | Article |
| series | Revista Finlay |
| spelling | doaj-art-59dba8141ea741e9b28a74bd27af4f352025-01-30T21:21:58ZspaUniversidad de las Ciencias Médicas de CienfuegosRevista Finlay2221-24342017-04-01727273315CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in CienfuegosYoana Herrera Leiva0Teresita Sabatés Llerandi1Hospital General Universitario Dr. Gustavo Aldereguía Lima. Cienfuegos.Hospital General Universitario Dr. Gustavo Aldereguía Lima. Cienfuegos.In 2016, the EGF-Predictor Phase IV Clinical Trial Opening Workshop was held in Cienfuegos, sponsored by the Center for Molecular Immunology of Havana which coexist with other clinical trials. The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic vaccine for the treatment of patients diagnosed with lung cancer in advanced stages of the disease and, within its specific objectives, to assess overall survival and the treated patients’ life quality.https://revfinlay.sld.cu/index.php/finlay/article/view/531vacunas contra el cáncerneoplasias pulmonaresdiagnóstico clínicouso terapéuticosupervivenciaevaluación de medicamentos |
| spellingShingle | Yoana Herrera Leiva Teresita Sabatés Llerandi CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos Revista Finlay vacunas contra el cáncer neoplasias pulmonares diagnóstico clínico uso terapéutico supervivencia evaluación de medicamentos |
| title | CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos |
| title_full | CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos |
| title_fullStr | CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos |
| title_full_unstemmed | CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos |
| title_short | CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos |
| title_sort | cimavax egf r new therapeutic alternative for lung cancer its application in cienfuegos |
| topic | vacunas contra el cáncer neoplasias pulmonares diagnóstico clínico uso terapéutico supervivencia evaluación de medicamentos |
| url | https://revfinlay.sld.cu/index.php/finlay/article/view/531 |
| work_keys_str_mv | AT yoanaherreraleiva cimavaxegfnewtherapeuticalternativeforlungcanceritsapplicationincienfuegos AT teresitasabatesllerandi cimavaxegfnewtherapeuticalternativeforlungcanceritsapplicationincienfuegos |